A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Metastatic
Interventions: DRUG: Margetuximab|DRUG: Trastuzumab|DRUG: Chosen Chemotherapy (Capecitabine)|DRUG: Chosen Chemotherapy (Vinorelbine )|DRUG: Chosen Chemotherapy (Gemcitabine )
Sponsor: Zai Lab (Shanghai) Co., Ltd.